Reaction

Post Cholecystectomy Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 278 reports · 15 co-occurring drugs

As of the last recalculation, Post Cholecystectomy Syndrome appears in 278 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is DROSPIRENONE AND ETHINYL ESTRADIOL (PRR 1,067.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Drospirenone And Ethinyl Estradiol1931,067.11,071.8
Methylprednisolone Acetate22223.3223.9
Esomeprazole Magnesium Capsule, Delayed Release33193.1193.5
Esomeprazole Magnesium Delayed Release Capsules33193.1193.5
Esomeprazole Magnesium Dihydrate33192.2192.7
Diphenhydramine Hydrochloride Capsule, Liquid Filled41168.4168.7
Cetirizine Hydrochloride Allergy46136.1136.3
Cetirizine Hydrochloride Tablets46136.1136.3
Vitamin E40111.1111.2
Tapentadol Hydrochloride2664.164.1
Duloxetine4760.660.6
Cetirizine5058.658.6
Aripiprazole Oral2651.851.9
Aripiprazole Orally Disintegrating2651.851.9
Adapalene31.21.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.